01.11.2008 | Research Articles
Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer
Erschienen in: Clinical and Translational Oncology | Ausgabe 11/2008
Einloggen, um Zugang zu erhalten